Seven years after India legalized cannabis for medical and industrial purposes, the country is witnessing transformative changes in the healthcare sector. Spearheading this revolution is Karmosis, a Bengaluru-based startup that is pioneering the incorporation of Ayurvedic cannabis into modern wellness practices.
Ayurvedic cannabis products are derived from the revered herb ‘Vijaya’ and offer a range of health benefits.
Founded by Karan Naidu and Praveen Singh Rajput, Karmosis is at the forefront of this new wave. Their mission is to unlock the therapeutic benefits of cannabis, traditionally revered as “Vijaya” in Ayurveda, and bring it to the Indian public through innovative healthcare solutions. The company’s approach is made possible by receiving the necessary licenses from the Ministry of Ayurveda, Madhya Pradesh, which has played a key role in promoting cannabis manufacturing since 2019.
“Despite the legalization of cannabis in 2017, its applications in the medical field remain underutilized,” explains Karan Naidu. “At Karmosis, our goal is to bridge this gap and provide the best medical facilities to the public, leveraging the many health benefits of cannabis.”
“Our products are based on Ayurvedic principles and are guaranteed to be safe and effective,” Naidu continued. “We are excited about the potential of cannabis to improve physical and mental health, and are committed to making these benefits widely available.”
Apart from its innovative product line, Carmosis is also committed to ethical sourcing and sustainability. “We believe that you can do well by doing good,” said Praveen Singh Rajput, president and CEO of Carmosis. “Our future foray into the pet care industry will be focused on our products and services.
Karan Naidu and Praveen Singh Rajput are not only transforming the perception of cannabis, but also setting a new standard for natural Ayurvedic health solutions for the 21st century.
